More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Fetuin-A (AHSG) Human ELISA

Fetuin-A (AHSG) Human ELISA

Research Use Only
RD191037100
BioVendor
Assay Sample Typeserum and plasma (EDTA, citrate, heparin)
Product group Assays
Price on request
96 wells
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    BioVendor
  • Product Name
    Fetuin-A (AHSG) Human ELISA
  • Delivery Days Customer
    7
  • Applications
    ELISA
  • Assay Detection Range
    2 - 100 ng/ml
  • Assay Precision
    Inter assay: n = 6, CV = 4,7%, Intra assay: n = 8, CV = 2,9%,
  • Assay Sample Type
    serum and plasma (EDTA, citrate, heparin)
  • Assay Sensitivity
    0,104 ng/ml
  • Assay Time
    The total assay time is less than 3 hours
  • Certification
    Research Use Only
  • UNSPSC
    41116133

References

  • Abali R, Celik C, Tasdemir N, Guzel S, Alpsoy S, Yuksel A, Celik E. The serum protein alpha2-Heremans-Schmid glycoprotein/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Bi. 2013 Jul,169 (1):45-9
  • Aleksandrova K, Giuseppe RD, Isermann B, Biemann R, Schulze MB, Wittenbecher C, Fritsche A, Lehmann R, Menzel J, Weikert C, Pischon T, Boeing H. Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC Potsdam Cohort Study. Cancer Res. 2016 May 23
  • Argani H, Ghorbanihaghjo A, Panahi G, Rashtchizadeh N, Safa J, Meimand SM. Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients. Clin Biochem. 2012 Jul,45 (10-11):775-9
  • Bakiner O, Bozkirli E, Ertugrul D, Sezgin N, Ertorer E. Plasma fetuin-A levels are reduced in patients with hypothyroidism. Eur J Endocrinol. 2014 Mar,170 (3):411-8
  • Blaha V, Mistrik E, Dusilova-Sulkova S, Kalousova M, Andrys C, Blaha M, Sobotka L. Circulating fetuin-A predicts early mortality in chronic hemodialysis patients. Clin Biochem. 2009 Jul,42 (10-11):996-1000
  • Brettschneider J, Lehmensiek V, Mogel H, Pfeifle M, Dorst J, Hendrich C, Ludolph AC, Tumani H. Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS). Neurosci Lett. 2010 Jan 1,468 (1):23-7
  • Briana DD, Boutsikou M, Gourgiotis D, Boutsikou T, Baka S, Marmarinos A, Hassiakos D, Malamitsi-Puchner A. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth. J Matern Fetal Neonatal Med. 2008 Nov,21 (11):826-30
  • Brix JM, Stingl H, Hollerl F, Schernthaner GH, Kopp HP, Schernthaner G. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab. 2010 Nov,95 (11):4877-81
  • Caglar K, Yilmaz MI, Saglam M, Cakir E, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Vural A, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol. 2008 Jan,3 (1):61-8
  • Caglar K, Yilmaz MI, Saglam M, Cakir E, Kilic S, Sonmez A, Eyileten T, Yenicesu M, Oguz Y, Tasar M, Vural A, Ikizler TA, Stenvinkel P, Lindholm B. Serum fetuin-a concentration and endothelial dysfunction in chronic kidney disease. Nephron Clin Pract. 2008,108 (3):c233-40